Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward

Daniela Braida, Valeria Limonta, Valeria Capurro, Paola Fadda, Tiziana Rubino, Paola Mascia, Alessia Zani, Enzo Gori, Walter Fratta, Daniela Parolaro, Mariaelvina Sala

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Background: The recreational drug, Salvinorin A, derived from the plant of Salvia divinorum, is a potent and selective κ-opioid receptor agonist. The abuse of selective k-agonists is a novel phenomenon, the mechanism of which is not fully understood. Methods: We investigated salvinorin A given SC on the conditioned place preference (.05-160 μg/kg) and intracerebroventricular (ICV) self-administration (.01-1 μg/infusion) paradigms, in Wistar rats. Results: The present results demonstrate the rewarding effects of Salvinorin A in a range of doses between .1 and 40 μg/kg SC for conditioned place preference test and .1-.5 μg/infusion for ICV self-administration. Highest doses (160 μg/kg for conditioned place preference test and 1 μg/infusion for ICV self-administration) were aversive. The rewarding effect was antagonized by intraperitoneal (IP) pretreatment with the cannabinoid CB1 receptor antagonist, rimonabant [N-piperidino-5-(4-chlorophenyl)1-(2,4-dichloro phenyl)-4 methyl pyrazole 3-carboxamide] (1 mg/kg), and the κ-opioid receptor antagonist, nor-binaltorphimine (nor-BNI) (10 mg/kg). In the shell of nucleus accumbens, dopamine extracellular levels were increased after administration of salvinorin A (40 μg/kg SC), reaching a maximum value of about 150%. Conclusions: These data provide the demonstration of the rewarding effects of Salvinorin A through an interaction between κ-opioid and (endo)cannabinoid system in rats.

Original languageEnglish
Pages (from-to)286-292
Number of pages7
JournalBiological Psychiatry
Volume63
Issue number3
DOIs
Publication statusPublished - Feb 1 2008

Fingerprint

salvinorin A
Endocannabinoids
Reward
Opioid Analgesics
Self Administration
Intraventricular Infusions
rimonabant
Cannabinoid Receptor Antagonists
Salvia
Narcotic Antagonists
Cannabinoids
Nucleus Accumbens
Street Drugs
Opioid Receptors
Wistar Rats
Dopamine

Keywords

  • κ-opioid receptor
  • Conditioned place preference
  • dopamine
  • microdialysis
  • self-administration
  • SR 141716A

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Braida, D., Limonta, V., Capurro, V., Fadda, P., Rubino, T., Mascia, P., ... Sala, M. (2008). Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward. Biological Psychiatry, 63(3), 286-292. https://doi.org/10.1016/j.biopsych.2007.07.020

Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward. / Braida, Daniela; Limonta, Valeria; Capurro, Valeria; Fadda, Paola; Rubino, Tiziana; Mascia, Paola; Zani, Alessia; Gori, Enzo; Fratta, Walter; Parolaro, Daniela; Sala, Mariaelvina.

In: Biological Psychiatry, Vol. 63, No. 3, 01.02.2008, p. 286-292.

Research output: Contribution to journalArticle

Braida, D, Limonta, V, Capurro, V, Fadda, P, Rubino, T, Mascia, P, Zani, A, Gori, E, Fratta, W, Parolaro, D & Sala, M 2008, 'Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward', Biological Psychiatry, vol. 63, no. 3, pp. 286-292. https://doi.org/10.1016/j.biopsych.2007.07.020
Braida, Daniela ; Limonta, Valeria ; Capurro, Valeria ; Fadda, Paola ; Rubino, Tiziana ; Mascia, Paola ; Zani, Alessia ; Gori, Enzo ; Fratta, Walter ; Parolaro, Daniela ; Sala, Mariaelvina. / Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward. In: Biological Psychiatry. 2008 ; Vol. 63, No. 3. pp. 286-292.
@article{40477fa5747d48f6b4d2dd96b8ee1a9b,
title = "Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward",
abstract = "Background: The recreational drug, Salvinorin A, derived from the plant of Salvia divinorum, is a potent and selective κ-opioid receptor agonist. The abuse of selective k-agonists is a novel phenomenon, the mechanism of which is not fully understood. Methods: We investigated salvinorin A given SC on the conditioned place preference (.05-160 μg/kg) and intracerebroventricular (ICV) self-administration (.01-1 μg/infusion) paradigms, in Wistar rats. Results: The present results demonstrate the rewarding effects of Salvinorin A in a range of doses between .1 and 40 μg/kg SC for conditioned place preference test and .1-.5 μg/infusion for ICV self-administration. Highest doses (160 μg/kg for conditioned place preference test and 1 μg/infusion for ICV self-administration) were aversive. The rewarding effect was antagonized by intraperitoneal (IP) pretreatment with the cannabinoid CB1 receptor antagonist, rimonabant [N-piperidino-5-(4-chlorophenyl)1-(2,4-dichloro phenyl)-4 methyl pyrazole 3-carboxamide] (1 mg/kg), and the κ-opioid receptor antagonist, nor-binaltorphimine (nor-BNI) (10 mg/kg). In the shell of nucleus accumbens, dopamine extracellular levels were increased after administration of salvinorin A (40 μg/kg SC), reaching a maximum value of about 150{\%}. Conclusions: These data provide the demonstration of the rewarding effects of Salvinorin A through an interaction between κ-opioid and (endo)cannabinoid system in rats.",
keywords = "κ-opioid receptor, Conditioned place preference, dopamine, microdialysis, self-administration, SR 141716A",
author = "Daniela Braida and Valeria Limonta and Valeria Capurro and Paola Fadda and Tiziana Rubino and Paola Mascia and Alessia Zani and Enzo Gori and Walter Fratta and Daniela Parolaro and Mariaelvina Sala",
year = "2008",
month = "2",
day = "1",
doi = "10.1016/j.biopsych.2007.07.020",
language = "English",
volume = "63",
pages = "286--292",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Involvement of κ-Opioid and Endocannabinoid System on Salvinorin A-Induced Reward

AU - Braida, Daniela

AU - Limonta, Valeria

AU - Capurro, Valeria

AU - Fadda, Paola

AU - Rubino, Tiziana

AU - Mascia, Paola

AU - Zani, Alessia

AU - Gori, Enzo

AU - Fratta, Walter

AU - Parolaro, Daniela

AU - Sala, Mariaelvina

PY - 2008/2/1

Y1 - 2008/2/1

N2 - Background: The recreational drug, Salvinorin A, derived from the plant of Salvia divinorum, is a potent and selective κ-opioid receptor agonist. The abuse of selective k-agonists is a novel phenomenon, the mechanism of which is not fully understood. Methods: We investigated salvinorin A given SC on the conditioned place preference (.05-160 μg/kg) and intracerebroventricular (ICV) self-administration (.01-1 μg/infusion) paradigms, in Wistar rats. Results: The present results demonstrate the rewarding effects of Salvinorin A in a range of doses between .1 and 40 μg/kg SC for conditioned place preference test and .1-.5 μg/infusion for ICV self-administration. Highest doses (160 μg/kg for conditioned place preference test and 1 μg/infusion for ICV self-administration) were aversive. The rewarding effect was antagonized by intraperitoneal (IP) pretreatment with the cannabinoid CB1 receptor antagonist, rimonabant [N-piperidino-5-(4-chlorophenyl)1-(2,4-dichloro phenyl)-4 methyl pyrazole 3-carboxamide] (1 mg/kg), and the κ-opioid receptor antagonist, nor-binaltorphimine (nor-BNI) (10 mg/kg). In the shell of nucleus accumbens, dopamine extracellular levels were increased after administration of salvinorin A (40 μg/kg SC), reaching a maximum value of about 150%. Conclusions: These data provide the demonstration of the rewarding effects of Salvinorin A through an interaction between κ-opioid and (endo)cannabinoid system in rats.

AB - Background: The recreational drug, Salvinorin A, derived from the plant of Salvia divinorum, is a potent and selective κ-opioid receptor agonist. The abuse of selective k-agonists is a novel phenomenon, the mechanism of which is not fully understood. Methods: We investigated salvinorin A given SC on the conditioned place preference (.05-160 μg/kg) and intracerebroventricular (ICV) self-administration (.01-1 μg/infusion) paradigms, in Wistar rats. Results: The present results demonstrate the rewarding effects of Salvinorin A in a range of doses between .1 and 40 μg/kg SC for conditioned place preference test and .1-.5 μg/infusion for ICV self-administration. Highest doses (160 μg/kg for conditioned place preference test and 1 μg/infusion for ICV self-administration) were aversive. The rewarding effect was antagonized by intraperitoneal (IP) pretreatment with the cannabinoid CB1 receptor antagonist, rimonabant [N-piperidino-5-(4-chlorophenyl)1-(2,4-dichloro phenyl)-4 methyl pyrazole 3-carboxamide] (1 mg/kg), and the κ-opioid receptor antagonist, nor-binaltorphimine (nor-BNI) (10 mg/kg). In the shell of nucleus accumbens, dopamine extracellular levels were increased after administration of salvinorin A (40 μg/kg SC), reaching a maximum value of about 150%. Conclusions: These data provide the demonstration of the rewarding effects of Salvinorin A through an interaction between κ-opioid and (endo)cannabinoid system in rats.

KW - κ-opioid receptor

KW - Conditioned place preference

KW - dopamine

KW - microdialysis

KW - self-administration

KW - SR 141716A

UR - http://www.scopus.com/inward/record.url?scp=38049032934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049032934&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2007.07.020

DO - 10.1016/j.biopsych.2007.07.020

M3 - Article

C2 - 17920565

AN - SCOPUS:38049032934

VL - 63

SP - 286

EP - 292

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 3

ER -